Literature DB >> 8530424

The TATA-less promoter of mouse ribonucleotide reductase R1 gene contains a TFII-I binding initiator element essential for cell cycle-regulated transcription.

E Johansson1, E Skogman, L Thelander.   

Abstract

Mammalian ribonucleotide reductase shows S-phase specific expression and consists of two non-identical subunits, proteins R1 (large subunit) and R2 (small subunit). A comparison between the human and mouse TATA-less R1 gene promoters revealed four highly conserved DNA regions, while the remaining sequence showed a low degree of conservation. Two regions, alpha and beta, were earlier identified as protein binding regions in the mouse R1 promoter by using DNase footprinting technique. The two new regions are located to the transcription start and to a DNA sequence about 40 base pairs downstream from the start. Gel shift assays using TFII-I antibodies and competition with an oligonucleotide representing the terminal deoxynucleotidyl transferase inhibitor element identified the start region as a TFII-I binding initiator element. The conserved downstream region, called gamma, also formed specific DNA-protein complexes in gel shift assays. Functional studies, using synchronized cells stably transformed by R1 promoter-luciferase reporter gene constructs, indicated that the initiator and the gamma elements together were necessary for cell cycle-regulated R1 promoter activity. Earlier published data, indicating Sp1 binding to the R1 alpha/beta regions, could not be confirmed, suggesting that the R1 initiator element may function independent of Sp1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530424     DOI: 10.1074/jbc.270.50.30162

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.

Authors:  C M Mobley; L Sealy
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Regulation of the rose Rh-PIP2;1 promoter by hormones and abiotic stresses in Arabidopsis.

Authors:  Yunhui Li; Ziyan Wu; Nan Ma; Junping Gao
Journal:  Plant Cell Rep       Date:  2008-11-05       Impact factor: 4.570

3.  TFII-I regulates Vbeta promoter activity through an initiator element.

Authors:  V Cheriyath; C D Novina; A L Roy
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

4.  A stimulation-dependent alternate core promoter links lymphotoxin α expression with TGF-β1 and fibroblast growth factor-7 signaling in primary human T cells.

Authors:  Brian H Yokley; Sandra T Selby; Phillip E Posch
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

5.  Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: implication in phorbol ester-induced tumour promotion.

Authors:  I Eto
Journal:  Cell Prolif       Date:  2000-06       Impact factor: 6.831

6.  Accurate positioning of RNA polymerase II on a natural TATA-less promoter is independent of TATA-binding-protein-associated factors and initiator-binding proteins.

Authors:  L Weis; D Reinberg
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

7.  Cell cycle regulation of the tobacco ribonucleotide reductase small subunit gene is mediated by E2F-like elements.

Authors:  M E Chabouté; B Clément; M Sekine; G Philipps; N Chaubet-Gigot
Journal:  Plant Cell       Date:  2000-10       Impact factor: 11.277

8.  A human protein related to yeast Cdc6p.

Authors:  R S Williams; R V Shohet; B Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

9.  Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis.

Authors:  Jana S Eaton; Z Ping Lin; Alan C Sartorelli; Nicholas D Bonawitz; Gerald S Shadel
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.

Authors:  C M Mobley; L Sealy
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.